The global market for Breath-activated Dry Powder Inhaler was valued at US$ 779 million in the year 2024 and is projected to reach a revised size of US$ 1083 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Breath-activated Dry Powder Inhaler Market

The breath-activated dry powder inhaler (DPI) market showcases a promising trajectory driven by several factors. The demand for DPIs has surged due to their user-friendly design, eliminating the need for coordination between inhalation and device actuation, thus catering to diverse patient groups, including elderly and pediatric populations. Advancements in respiratory disease management and the preference for DPIs over traditional metered-dose inhalers (MDIs) due to environmental concerns related to propellant gases contribute to market growth. Additionally, technological innovations enhancing DPI efficacy, such as dose consistency and lung deposition, have bolstered their adoption. However, market expansion faces challenges like the high cost of developing DPIs with advanced features, regulatory hurdles, and limited access to these devices in developing regions, hindering market penetration. Moreover, competition among pharmaceutical companies to develop novel DPI formulations and the need for extensive clinical validation pose barriers to entry, influencing the market landscape. Despite hindrances, the breath-activated DPI market is poised for growth, fueled by increasing respiratory disorders and ongoing research to improve device effectiveness and patient compliance.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Breath-activated Dry Powder Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breath-activated Dry Powder Inhaler.

The Breath-activated Dry Powder Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breath-activated Dry Powder Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breath-activated Dry Powder Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Breath-activated Dry Powder Inhaler Market Report

Report Metric	Details
Report Name	Breath-activated Dry Powder Inhaler Market
Accounted market size in year	US$ 779 million
Forecasted market size in 2031	US$ 1083 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Capsule Based Dry Powder Inhaler Blister Based Dry Powder Inhaler Canister/Cartridge Based Others
Segment by Application	Asthma Anti-infective Rescue Vaccine Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, 3M, AstraZeneca, Chiesi Farmaceutici, Hovione, MannKind, Viatris, Teva Pharmaceuticals, Changzhou DSB Medical, Boehringer Ingelheim, Cipla, Novartis Pharmaceuticals, Merck, Sumitomo Pharma America, Eskayef Pharmaceuticals, PharmEvo, Getz Pharma, Suzhou Inhal Pharma, Iconovo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Breath-activated Dry Powder Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Breath-activated Dry Powder Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Breath-activated Dry Powder Inhaler Market growing?

Ans: The Breath-activated Dry Powder Inhaler Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Breath-activated Dry Powder Inhaler Market size in 2031?

Ans: The Breath-activated Dry Powder Inhaler Market size in 2031 will be US$ 1083 million.

Who are the main players in the Breath-activated Dry Powder Inhaler Market report?

Ans: The main players in the Breath-activated Dry Powder Inhaler Market are GSK, 3M, AstraZeneca, Chiesi Farmaceutici, Hovione, MannKind, Viatris, Teva Pharmaceuticals, Changzhou DSB Medical, Boehringer Ingelheim, Cipla, Novartis Pharmaceuticals, Merck, Sumitomo Pharma America, Eskayef Pharmaceuticals, PharmEvo, Getz Pharma, Suzhou Inhal Pharma, Iconovo

What are the Application segmentation covered in the Breath-activated Dry Powder Inhaler Market report?

Ans: The Applications covered in the Breath-activated Dry Powder Inhaler Market report are Asthma, Anti-infective, Rescue, Vaccine, Others

What are the Type segmentation covered in the Breath-activated Dry Powder Inhaler Market report?

Ans: The Types covered in the Breath-activated Dry Powder Inhaler Market report are Capsule Based Dry Powder Inhaler, Blister Based Dry Powder Inhaler, Canister/Cartridge Based, Others

1 Breath-activated Dry Powder Inhaler Market Overview

1.1 Product Definition

1.2 Breath-activated Dry Powder Inhaler by Type

1.2.1 Global Breath-activated Dry Powder Inhaler Market Value Comparison by Type (2024 VS 2031)

1.2.2 Capsule Based Dry Powder Inhaler

1.2.3 Blister Based Dry Powder Inhaler

1.2.4 Canister/Cartridge Based

1.2.5 Others

1.3 Breath-activated Dry Powder Inhaler by Application

1.3.1 Global Breath-activated Dry Powder Inhaler Market Value by Application (2024 VS 2031)

1.3.2 Asthma

1.3.3 Anti-infective

1.3.4 Rescue

1.3.5 Vaccine

1.3.6 Others

1.4 Global Breath-activated Dry Powder Inhaler Market Size Estimates and Forecasts

1.4.1 Global Breath-activated Dry Powder Inhaler Revenue 2020-2031

1.4.2 Global Breath-activated Dry Powder Inhaler Sales 2020-2031

1.4.3 Global Breath-activated Dry Powder Inhaler Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Breath-activated Dry Powder Inhaler Market Competition by Manufacturers

2.1 Global Breath-activated Dry Powder Inhaler Sales Market Share by Manufacturers (2020-2025)

2.2 Global Breath-activated Dry Powder Inhaler Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Breath-activated Dry Powder Inhaler Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Breath-activated Dry Powder Inhaler, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Product Type & Application

2.7 Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Date of Enter into This Industry

2.8 Global Breath-activated Dry Powder Inhaler Market Competitive Situation and Trends

2.8.1 Global Breath-activated Dry Powder Inhaler Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Breath-activated Dry Powder Inhaler Players Market Share by Revenue

2.8.3 Global Breath-activated Dry Powder Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Breath-activated Dry Powder Inhaler Market Scenario by Region

3.1 Global Breath-activated Dry Powder Inhaler Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Breath-activated Dry Powder Inhaler Sales by Region: 2020-2031

3.2.1 Global Breath-activated Dry Powder Inhaler Sales by Region: 2020-2025

3.2.2 Global Breath-activated Dry Powder Inhaler Sales by Region: 2026-2031

3.3 Global Breath-activated Dry Powder Inhaler Revenue by Region: 2020-2031

3.3.1 Global Breath-activated Dry Powder Inhaler Revenue by Region: 2020-2025

3.3.2 Global Breath-activated Dry Powder Inhaler Revenue by Region: 2026-2031

3.4 North America Breath-activated Dry Powder Inhaler Market Facts & Figures by Country

3.4.1 North America Breath-activated Dry Powder Inhaler Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Breath-activated Dry Powder Inhaler Sales by Country (2020-2031)

3.4.3 North America Breath-activated Dry Powder Inhaler Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Breath-activated Dry Powder Inhaler Market Facts & Figures by Country

3.5.1 Europe Breath-activated Dry Powder Inhaler Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Breath-activated Dry Powder Inhaler Sales by Country (2020-2031)

3.5.3 Europe Breath-activated Dry Powder Inhaler Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Breath-activated Dry Powder Inhaler Market Facts & Figures by Region

3.6.1 Asia Pacific Breath-activated Dry Powder Inhaler Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Breath-activated Dry Powder Inhaler Sales by Region (2020-2031)

3.6.3 Asia Pacific Breath-activated Dry Powder Inhaler Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Breath-activated Dry Powder Inhaler Market Facts & Figures by Country

3.7.1 Latin America Breath-activated Dry Powder Inhaler Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Breath-activated Dry Powder Inhaler Sales by Country (2020-2031)

3.7.3 Latin America Breath-activated Dry Powder Inhaler Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Breath-activated Dry Powder Inhaler Market Facts & Figures by Country

3.8.1 Middle East and Africa Breath-activated Dry Powder Inhaler Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Breath-activated Dry Powder Inhaler Sales by Country (2020-2031)

3.8.3 Middle East and Africa Breath-activated Dry Powder Inhaler Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Breath-activated Dry Powder Inhaler Sales by Type (2020-2031)

4.1.1 Global Breath-activated Dry Powder Inhaler Sales by Type (2020-2025)

4.1.2 Global Breath-activated Dry Powder Inhaler Sales by Type (2026-2031)

4.1.3 Global Breath-activated Dry Powder Inhaler Sales Market Share by Type (2020-2031)

4.2 Global Breath-activated Dry Powder Inhaler Revenue by Type (2020-2031)

4.2.1 Global Breath-activated Dry Powder Inhaler Revenue by Type (2020-2025)

4.2.2 Global Breath-activated Dry Powder Inhaler Revenue by Type (2026-2031)

4.2.3 Global Breath-activated Dry Powder Inhaler Revenue Market Share by Type (2020-2031)

4.3 Global Breath-activated Dry Powder Inhaler Price by Type (2020-2031)

5 Segment by Application

5.1 Global Breath-activated Dry Powder Inhaler Sales by Application (2020-2031)

5.1.1 Global Breath-activated Dry Powder Inhaler Sales by Application (2020-2025)

5.1.2 Global Breath-activated Dry Powder Inhaler Sales by Application (2026-2031)

5.1.3 Global Breath-activated Dry Powder Inhaler Sales Market Share by Application (2020-2031)

5.2 Global Breath-activated Dry Powder Inhaler Revenue by Application (2020-2031)

5.2.1 Global Breath-activated Dry Powder Inhaler Revenue by Application (2020-2025)

5.2.2 Global Breath-activated Dry Powder Inhaler Revenue by Application (2026-2031)

5.2.3 Global Breath-activated Dry Powder Inhaler Revenue Market Share by Application (2020-2031)

5.3 Global Breath-activated Dry Powder Inhaler Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Company Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK Breath-activated Dry Powder Inhaler Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 3M

6.2.1 3M Company Information

6.2.2 3M Description and Business Overview

6.2.3 3M Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.2.4 3M Breath-activated Dry Powder Inhaler Product Portfolio

6.2.5 3M Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Company Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AstraZeneca Breath-activated Dry Powder Inhaler Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Chiesi Farmaceutici

6.4.1 Chiesi Farmaceutici Company Information

6.4.2 Chiesi Farmaceutici Description and Business Overview

6.4.3 Chiesi Farmaceutici Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Chiesi Farmaceutici Breath-activated Dry Powder Inhaler Product Portfolio

6.4.5 Chiesi Farmaceutici Recent Developments/Updates

6.5 Hovione

6.5.1 Hovione Company Information

6.5.2 Hovione Description and Business Overview

6.5.3 Hovione Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hovione Breath-activated Dry Powder Inhaler Product Portfolio

6.5.5 Hovione Recent Developments/Updates

6.6 MannKind

6.6.1 MannKind Company Information

6.6.2 MannKind Description and Business Overview

6.6.3 MannKind Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.6.4 MannKind Breath-activated Dry Powder Inhaler Product Portfolio

6.6.5 MannKind Recent Developments/Updates

6.7 Viatris

6.7.1 Viatris Company Information

6.7.2 Viatris Description and Business Overview

6.7.3 Viatris Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Viatris Breath-activated Dry Powder Inhaler Product Portfolio

6.7.5 Viatris Recent Developments/Updates

6.8 Teva Pharmaceuticals

6.8.1 Teva Pharmaceuticals Company Information

6.8.2 Teva Pharmaceuticals Description and Business Overview

6.8.3 Teva Pharmaceuticals Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Teva Pharmaceuticals Breath-activated Dry Powder Inhaler Product Portfolio

6.8.5 Teva Pharmaceuticals Recent Developments/Updates

6.9 Changzhou DSB Medical

6.9.1 Changzhou DSB Medical Company Information

6.9.2 Changzhou DSB Medical Description and Business Overview

6.9.3 Changzhou DSB Medical Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Changzhou DSB Medical Breath-activated Dry Powder Inhaler Product Portfolio

6.9.5 Changzhou DSB Medical Recent Developments/Updates

6.10 Boehringer Ingelheim

6.10.1 Boehringer Ingelheim Company Information

6.10.2 Boehringer Ingelheim Description and Business Overview

6.10.3 Boehringer Ingelheim Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Boehringer Ingelheim Breath-activated Dry Powder Inhaler Product Portfolio

6.10.5 Boehringer Ingelheim Recent Developments/Updates

6.11 Cipla

6.11.1 Cipla Company Information

6.11.2 Cipla Description and Business Overview

6.11.3 Cipla Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Cipla Breath-activated Dry Powder Inhaler Product Portfolio

6.11.5 Cipla Recent Developments/Updates

6.12 Novartis Pharmaceuticals

6.12.1 Novartis Pharmaceuticals Company Information

6.12.2 Novartis Pharmaceuticals Description and Business Overview

6.12.3 Novartis Pharmaceuticals Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Novartis Pharmaceuticals Breath-activated Dry Powder Inhaler Product Portfolio

6.12.5 Novartis Pharmaceuticals Recent Developments/Updates

6.13 Merck

6.13.1 Merck Company Information

6.13.2 Merck Description and Business Overview

6.13.3 Merck Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Merck Breath-activated Dry Powder Inhaler Product Portfolio

6.13.5 Merck Recent Developments/Updates

6.14 Sumitomo Pharma America

6.14.1 Sumitomo Pharma America Company Information

6.14.2 Sumitomo Pharma America Description and Business Overview

6.14.3 Sumitomo Pharma America Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Sumitomo Pharma America Breath-activated Dry Powder Inhaler Product Portfolio

6.14.5 Sumitomo Pharma America Recent Developments/Updates

6.15 Eskayef Pharmaceuticals

6.15.1 Eskayef Pharmaceuticals Company Information

6.15.2 Eskayef Pharmaceuticals Description and Business Overview

6.15.3 Eskayef Pharmaceuticals Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Eskayef Pharmaceuticals Breath-activated Dry Powder Inhaler Product Portfolio

6.15.5 Eskayef Pharmaceuticals Recent Developments/Updates

6.16 PharmEvo

6.16.1 PharmEvo Company Information

6.16.2 PharmEvo Description and Business Overview

6.16.3 PharmEvo Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.16.4 PharmEvo Breath-activated Dry Powder Inhaler Product Portfolio

6.16.5 PharmEvo Recent Developments/Updates

6.17 Getz Pharma

6.17.1 Getz Pharma Company Information

6.17.2 Getz Pharma Description and Business Overview

6.17.3 Getz Pharma Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Getz Pharma Breath-activated Dry Powder Inhaler Product Portfolio

6.17.5 Getz Pharma Recent Developments/Updates

6.18 Suzhou Inhal Pharma

6.18.1 Suzhou Inhal Pharma Company Information

6.18.2 Suzhou Inhal Pharma Description and Business Overview

6.18.3 Suzhou Inhal Pharma Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Suzhou Inhal Pharma Breath-activated Dry Powder Inhaler Product Portfolio

6.18.5 Suzhou Inhal Pharma Recent Developments/Updates

6.19 Iconovo

6.19.1 Iconovo Company Information

6.19.2 Iconovo Description and Business Overview

6.19.3 Iconovo Breath-activated Dry Powder Inhaler Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Iconovo Breath-activated Dry Powder Inhaler Product Portfolio

6.19.5 Iconovo Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Breath-activated Dry Powder Inhaler Industry Chain Analysis

7.2 Breath-activated Dry Powder Inhaler Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Breath-activated Dry Powder Inhaler Production Mode & Process Analysis

7.4 Breath-activated Dry Powder Inhaler Sales and Marketing

7.4.1 Breath-activated Dry Powder Inhaler Sales Channels

7.4.2 Breath-activated Dry Powder Inhaler Distributors

7.5 Breath-activated Dry Powder Inhaler Customer Analysis

8 Breath-activated Dry Powder Inhaler Market Dynamics

8.1 Breath-activated Dry Powder Inhaler Industry Trends

8.2 Breath-activated Dry Powder Inhaler Market Drivers

8.3 Breath-activated Dry Powder Inhaler Market Challenges

8.4 Breath-activated Dry Powder Inhaler Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novartis Pharmaceuticals

Merck

Eskayef Pharmaceuticals

Getz Pharma

Iconovo AB

Changzhou DSB Medical

Sumitomo Pharma America

PharmEvo

Suzhou Inhal Pharma

List of Tables

Table 1. Global Breath-activated Dry Powder Inhaler Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Breath-activated Dry Powder Inhaler Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Breath-activated Dry Powder Inhaler Market Competitive Situation by Manufacturers in 2024

Table 4. Global Breath-activated Dry Powder Inhaler Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Breath-activated Dry Powder Inhaler Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Breath-activated Dry Powder Inhaler Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Breath-activated Dry Powder Inhaler Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Breath-activated Dry Powder Inhaler Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Breath-activated Dry Powder Inhaler, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Product Type & Application

Table 12. Global Key Manufacturers of Breath-activated Dry Powder Inhaler, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Breath-activated Dry Powder Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breath-activated Dry Powder Inhaler as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Breath-activated Dry Powder Inhaler Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Breath-activated Dry Powder Inhaler Sales by Region (2020-2025) & (K Units)

Table 18. Global Breath-activated Dry Powder Inhaler Sales Market Share by Region (2020-2025)

Table 19. Global Breath-activated Dry Powder Inhaler Sales by Region (2026-2031) & (K Units)

Table 20. Global Breath-activated Dry Powder Inhaler Sales Market Share by Region (2026-2031)

Table 21. Global Breath-activated Dry Powder Inhaler Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Region (2020-2025)

Table 23. Global Breath-activated Dry Powder Inhaler Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Region (2026-2031)

Table 25. North America Breath-activated Dry Powder Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Breath-activated Dry Powder Inhaler Sales by Country (2020-2025) & (K Units)

Table 27. North America Breath-activated Dry Powder Inhaler Sales by Country (2026-2031) & (K Units)

Table 28. North America Breath-activated Dry Powder Inhaler Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Breath-activated Dry Powder Inhaler Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Breath-activated Dry Powder Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Breath-activated Dry Powder Inhaler Sales by Country (2020-2025) & (K Units)

Table 32. Europe Breath-activated Dry Powder Inhaler Sales by Country (2026-2031) & (K Units)

Table 33. Europe Breath-activated Dry Powder Inhaler Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Breath-activated Dry Powder Inhaler Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Breath-activated Dry Powder Inhaler Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Breath-activated Dry Powder Inhaler Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Breath-activated Dry Powder Inhaler Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Breath-activated Dry Powder Inhaler Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Breath-activated Dry Powder Inhaler Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Breath-activated Dry Powder Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Breath-activated Dry Powder Inhaler Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Breath-activated Dry Powder Inhaler Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Breath-activated Dry Powder Inhaler Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Breath-activated Dry Powder Inhaler Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Breath-activated Dry Powder Inhaler Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Breath-activated Dry Powder Inhaler Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Breath-activated Dry Powder Inhaler Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Breath-activated Dry Powder Inhaler Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Breath-activated Dry Powder Inhaler Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Breath-activated Dry Powder Inhaler Sales (K Units) by Type (2020-2025)

Table 51. Global Breath-activated Dry Powder Inhaler Sales (K Units) by Type (2026-2031)

Table 52. Global Breath-activated Dry Powder Inhaler Sales Market Share by Type (2020-2025)

Table 53. Global Breath-activated Dry Powder Inhaler Sales Market Share by Type (2026-2031)

Table 54. Global Breath-activated Dry Powder Inhaler Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Breath-activated Dry Powder Inhaler Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Type (2020-2025)

Table 57. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Type (2026-2031)

Table 58. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Type (2020-2025)

Table 59. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Type (2026-2031)

Table 60. Global Breath-activated Dry Powder Inhaler Sales (K Units) by Application (2020-2025)

Table 61. Global Breath-activated Dry Powder Inhaler Sales (K Units) by Application (2026-2031)

Table 62. Global Breath-activated Dry Powder Inhaler Sales Market Share by Application (2020-2025)

Table 63. Global Breath-activated Dry Powder Inhaler Sales Market Share by Application (2026-2031)

Table 64. Global Breath-activated Dry Powder Inhaler Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Breath-activated Dry Powder Inhaler Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Application (2020-2025)

Table 67. Global Breath-activated Dry Powder Inhaler Revenue Market Share by Application (2026-2031)

Table 68. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Application (2020-2025)

Table 69. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Application (2026-2031)

Table 70. GSK Company Information

Table 71. GSK Description and Business Overview

Table 72. GSK Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. GSK Breath-activated Dry Powder Inhaler Product

Table 74. GSK Recent Developments/Updates

Table 75. 3M Company Information

Table 76. 3M Description and Business Overview

Table 77. 3M Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. 3M Breath-activated Dry Powder Inhaler Product

Table 79. 3M Recent Developments/Updates

Table 80. AstraZeneca Company Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AstraZeneca Breath-activated Dry Powder Inhaler Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Chiesi Farmaceutici Company Information

Table 86. Chiesi Farmaceutici Description and Business Overview

Table 87. Chiesi Farmaceutici Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Chiesi Farmaceutici Breath-activated Dry Powder Inhaler Product

Table 89. Chiesi Farmaceutici Recent Developments/Updates

Table 90. Hovione Company Information

Table 91. Hovione Description and Business Overview

Table 92. Hovione Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Hovione Breath-activated Dry Powder Inhaler Product

Table 94. Hovione Recent Developments/Updates

Table 95. MannKind Company Information

Table 96. MannKind Description and Business Overview

Table 97. MannKind Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. MannKind Breath-activated Dry Powder Inhaler Product

Table 99. MannKind Recent Developments/Updates

Table 100. Viatris Company Information

Table 101. Viatris Description and Business Overview

Table 102. Viatris Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Viatris Breath-activated Dry Powder Inhaler Product

Table 104. Viatris Recent Developments/Updates

Table 105. Teva Pharmaceuticals Company Information

Table 106. Teva Pharmaceuticals Description and Business Overview

Table 107. Teva Pharmaceuticals Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Teva Pharmaceuticals Breath-activated Dry Powder Inhaler Product

Table 109. Teva Pharmaceuticals Recent Developments/Updates

Table 110. Changzhou DSB Medical Company Information

Table 111. Changzhou DSB Medical Description and Business Overview

Table 112. Changzhou DSB Medical Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Changzhou DSB Medical Breath-activated Dry Powder Inhaler Product

Table 114. Changzhou DSB Medical Recent Developments/Updates

Table 115. Boehringer Ingelheim Company Information

Table 116. Boehringer Ingelheim Description and Business Overview

Table 117. Boehringer Ingelheim Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Boehringer Ingelheim Breath-activated Dry Powder Inhaler Product

Table 119. Boehringer Ingelheim Recent Developments/Updates

Table 120. Cipla Company Information

Table 121. Cipla Description and Business Overview

Table 122. Cipla Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Cipla Breath-activated Dry Powder Inhaler Product

Table 124. Cipla Recent Developments/Updates

Table 125. Novartis Pharmaceuticals Company Information

Table 126. Novartis Pharmaceuticals Description and Business Overview

Table 127. Novartis Pharmaceuticals Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Novartis Pharmaceuticals Breath-activated Dry Powder Inhaler Product

Table 129. Novartis Pharmaceuticals Recent Developments/Updates

Table 130. Merck Company Information

Table 131. Merck Description and Business Overview

Table 132. Merck Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Merck Breath-activated Dry Powder Inhaler Product

Table 134. Merck Recent Developments/Updates

Table 135. Sumitomo Pharma America Company Information

Table 136. Sumitomo Pharma America Description and Business Overview

Table 137. Sumitomo Pharma America Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Sumitomo Pharma America Breath-activated Dry Powder Inhaler Product

Table 139. Sumitomo Pharma America Recent Developments/Updates

Table 140. Eskayef Pharmaceuticals Company Information

Table 141. Eskayef Pharmaceuticals Description and Business Overview

Table 142. Eskayef Pharmaceuticals Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Eskayef Pharmaceuticals Breath-activated Dry Powder Inhaler Product

Table 144. Eskayef Pharmaceuticals Recent Developments/Updates

Table 145. PharmEvo Company Information

Table 146. PharmEvo Description and Business Overview

Table 147. PharmEvo Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. PharmEvo Breath-activated Dry Powder Inhaler Product

Table 149. PharmEvo Recent Developments/Updates

Table 150. Getz Pharma Company Information

Table 151. Getz Pharma Description and Business Overview

Table 152. Getz Pharma Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Getz Pharma Breath-activated Dry Powder Inhaler Product

Table 154. Getz Pharma Recent Developments/Updates

Table 155. Suzhou Inhal Pharma Company Information

Table 156. Suzhou Inhal Pharma Description and Business Overview

Table 157. Suzhou Inhal Pharma Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 158. Suzhou Inhal Pharma Breath-activated Dry Powder Inhaler Product

Table 159. Suzhou Inhal Pharma Recent Developments/Updates

Table 160. Iconovo Company Information

Table 161. Iconovo Description and Business Overview

Table 162. Iconovo Breath-activated Dry Powder Inhaler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 163. Iconovo Breath-activated Dry Powder Inhaler Product

Table 164. Iconovo Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Breath-activated Dry Powder Inhaler Distributors List

Table 168. Breath-activated Dry Powder Inhaler Customers List

Table 169. Breath-activated Dry Powder Inhaler Market Trends

Table 170. Breath-activated Dry Powder Inhaler Market Drivers

Table 171. Breath-activated Dry Powder Inhaler Market Challenges

Table 172. Breath-activated Dry Powder Inhaler Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Breath-activated Dry Powder Inhaler

Figure 2. Global Breath-activated Dry Powder Inhaler Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Breath-activated Dry Powder Inhaler Market Share by Type: 2024 & 2031

Figure 4. Capsule Based Dry Powder Inhaler Product Picture

Figure 5. Blister Based Dry Powder Inhaler Product Picture

Figure 6. Canister/Cartridge Based Product Picture

Figure 7. Others Product Picture

Figure 8. Global Breath-activated Dry Powder Inhaler Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Breath-activated Dry Powder Inhaler Market Share by Application: 2024 & 2031

Figure 10. Asthma

Figure 11. Anti-infective

Figure 12. Rescue

Figure 13. Vaccine

Figure 14. Others

Figure 15. Global Breath-activated Dry Powder Inhaler Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Breath-activated Dry Powder Inhaler Market Size (2020-2031) & (US$ Million)

Figure 17. Global Breath-activated Dry Powder Inhaler Sales (2020-2031) & (K Units)

Figure 18. Global Breath-activated Dry Powder Inhaler Average Price (US$/Unit) & (2020-2031)

Figure 19. Breath-activated Dry Powder Inhaler Report Years Considered

Figure 20. Breath-activated Dry Powder Inhaler Sales Share by Manufacturers in 2024

Figure 21. Global Breath-activated Dry Powder Inhaler Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Breath-activated Dry Powder Inhaler Players: Market Share by Revenue in Breath-activated Dry Powder Inhaler in 2024

Figure 23. Breath-activated Dry Powder Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Breath-activated Dry Powder Inhaler Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Breath-activated Dry Powder Inhaler Sales Market Share by Country (2020-2031)

Figure 26. North America Breath-activated Dry Powder Inhaler Revenue Market Share by Country (2020-2031)

Figure 27. United States Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Breath-activated Dry Powder Inhaler Sales Market Share by Country (2020-2031)

Figure 30. Europe Breath-activated Dry Powder Inhaler Revenue Market Share by Country (2020-2031)

Figure 31. Germany Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Breath-activated Dry Powder Inhaler Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Breath-activated Dry Powder Inhaler Revenue Market Share by Region (2020-2031)

Figure 38. China Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Breath-activated Dry Powder Inhaler Sales Market Share by Country (2020-2031)

Figure 46. Latin America Breath-activated Dry Powder Inhaler Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Breath-activated Dry Powder Inhaler Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Breath-activated Dry Powder Inhaler Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Breath-activated Dry Powder Inhaler Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Breath-activated Dry Powder Inhaler by Type (2020-2031)

Figure 56. Global Revenue Market Share of Breath-activated Dry Powder Inhaler by Type (2020-2031)

Figure 57. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Breath-activated Dry Powder Inhaler by Application (2020-2031)

Figure 59. Global Revenue Market Share of Breath-activated Dry Powder Inhaler by Application (2020-2031)

Figure 60. Global Breath-activated Dry Powder Inhaler Price (US$/Unit) by Application (2020-2031)

Figure 61. Breath-activated Dry Powder Inhaler Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Asthma Monitoring Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5Y16546

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Respiratory Disease Test Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2Q16721

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Breath-activated Dry Powder Inhaler Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28Z16251

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Respiratory System Chronic Disease Inhalation Preparation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24R16205

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions